Analysis of assisted reproductive outcomes in patients with atypical endometrial hyperplasia and early‐stage endometrial cancer after fertility‐sparing treatment
International Journal of Gynecology & Obstetrics · 2025-02 · 168 (2) · 598-604
DOI: 10.1002/ijgo.15898 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Gynecology & Obstetrics, online erschienen am 15.09.2024. Verfasst von Jiaheng Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Reproduction Center, The Third Affiliated Hospital of Zheng Zhou University, Henan, China. Hauptthemen laut MEDLINE: Endometrial Hyperplasia, Endometrial Neoplasms, Fertility Preservation. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 24 Literaturangaben. Gefördert von: China Postdoctoral Science Foundation, National Key R&D Program.
Abstract (Originalsprache)
Objective
To explore the assisted reproductive outcomes of patients with atypical endometrial hyperplasia (AEH) and early‐stage endometrial cancer (EEC) who achieved complete remission after conservative treatment and to provide reference for clinical selection of appropriate conservative treatment.
Method
This retrospective cohort study included seven patients with EEC and 62 patients with AEH who underwent in vitro fertilization or intracytoplasmic sperm injection at the Reproductive Center of the Third Affiliated Hospital of Zhengzhou University between August 2015 and October 2023. The authors divided the participants into two groups based on the type of fertility‐sparing treatment received: the oral medication group and the levonorgestrel‐releasing intrauterine system (LNG‐IUS) group. The primary outcome was the cumulative clinical pregnancy rate. Secondary outcomes included clinical pregnancy rate per transfer cycle, embryo utilization rate, and high‐quality embryo rate.
Results
The LNG‐IUS group had a significantly higher rate of usable embryos compared with the oral medication group (80.8% vs 91.1%, P = 0.005) and also had a thinner endometrial thickness on the day of embryo transfer. The cumulative clinical pregnancy rate was higher in the LNG‐IUS group compared with the medication group (46.7% vs 78.9%, P = 0.037), and the difference was statistically significant.
Conclusion
For patients with AEH and EEC with fertility needs, the conservative treatment method of LNG‐IUS can achieve better assisted reproductive outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Reproduction Center, The Third Affiliated Hospital of Zheng Zhou University, Henan, China.
Förderung
- China Postdoctoral Science Foundation
- National Key R&D Program
Zitieren
APA
Li, J., Li, M., Li, Y., Zhao, X., Guan, Y., Yuan, X., Du, S., Zhang, C., Liu, W., & Ren, B. (2025). Analysis of assisted reproductive outcomes in patients with atypical endometrial hyperplasia and early‐stage endometrial cancer after fertility‐sparing treatment. International Journal of Gynecology & Obstetrics, 168(2), 598-604. https://doi.org/10.1002/ijgo.15898
Vancouver
Li J, Li M, Li Y, Zhao X, Guan Y, Yuan X, et al. Analysis of assisted reproductive outcomes in patients with atypical endometrial hyperplasia and early‐stage endometrial cancer after fertility‐sparing treatment. International Journal of Gynecology & Obstetrics. 2025;168(2):598-604. doi:10.1002/ijgo.15898
BibTeX
@article{Li2025,
author = {Li, Jiaheng and Li, Mengnuo and Li, Yijiang and Zhao, Xianling and Guan, Yichun and Yuan, Xiaoqiong and Du, Shanshan and Zhang, Caihua and Liu, Wenxia and Ren, Bingnan},
title = {Analysis of assisted reproductive outcomes in patients with atypical endometrial hyperplasia and early‐stage endometrial cancer after fertility‐sparing treatment},
journal = {International Journal of Gynecology & Obstetrics},
year = {2025},
volume = {168},
number = {2},
pages = {598--604},
doi = {10.1002/ijgo.15898}
}
EUVIMED